Survivin is the cause of tumor formation during embryonic stem cell therapy
Researchers from the Hebrew University in Jerusalem have proposed a method to reduce the risk of developing tumors using embryonic stem cells – suppressing the synthesis of a protein called survivin.
07.05.2009